#IPOupdate #IPOreview #IPO

Established in 2004, Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO). The company offers a comprehensive range of pharm products and services in India and overseas.

Akums Drugs and Pharmaceuticals Limited IPO will open for subscription on Tuesday, July 30, and is set to close for subscription on Thursday, August 1.

IPO Issue Details

Opens on: 30 July, 2024
Closes on: 1 Aug, 2024
Issue size: Rs. 1,856.74 crore
Fresh issue: Rs. 680 crore
Price band: Rs. 646-679 per share
Lot size: 22 shares per lot

In this video

00:00 Introduction
00:16 Akums Drugs and Pharma IPO issue details
00:36 About the company
02:18 Company’s revenue and net profits
02:40 Future key strategies
03:03 Objectives of the IPO

Read more here [ Ссылка ]

Tune in to know more about the company, IPO issue details, product/service portfolio, and much more with Kinjal Parekh!

Source: Company's RHP

Disc: [ Ссылка ]

#KotakSecurities #IPO #NewIPO #IPOReview #StockMarket #Trading #Investing #IssuePrize #LotSize #PriceBand


Kotak Securities is a preferred choice of millions of customers when it comes to investment decisions. With free access to credible research, competitive pricing, and high-speed trading platforms, it makes investing an effortless journey for both new investors and experienced traders. To open a FREE Demat and trading account with Kotak Securities, please click here: [ Ссылка ]

Disclaimer: [ Ссылка ]
-----------------------------------------------------------------------------------------------
To watch more videos on Stock Updates,
▶️ Subscribe to Kotak Securities & hit the 🔔 to watch our videos first. ​
🌐 LEARN MORE ABOUT STOCKS: [ Ссылка ]

------------------------------------------------------------------------------------------
FOLLOW US FOR STOCK UPDATES ON:
Telegram - [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
LinkedIn: [ Ссылка ]
Facebook: [ Ссылка ]
------------------------------------------------------------------------------------------
Customer Service: 1800 209 9191

We hope you enjoy your investment experience with us. If you have any other questions, please feel free to email our support team.

свернуть